Wockhardt Bionova Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 10-12-2024
- Paid Up Capital ₹ 0.50 M
as on 10-12-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
About Wockhardt Bionova
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Habil Khorakiwala, Murtaza Khorakiwala, and Zahabiya Khorakiwala serve as directors at the Company.
- CIN/LLPIN
U24299MH2021PLC363201
- Company No.
363201
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2021
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Wockhardt Bionova?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murtaza Khorakiwala  | Director | 02-Jul-2021 | Current |
| Habil Khorakiwala | Director | 02-Jul-2021 | Current |
| Zahabiya Khorakiwala | Director | 02-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Wockhardt Bionova.
Wockhardt Bionova Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Wockhardt Bionova?
Unlock access to Wockhardt Bionova's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Wockhardt Hospitals LimitedActive 33 years 3 monthsHabil Khorakiwala, Murtaza Khorakiwala and 1 more are mutual person
Wockhardt LimitedActive 25 years 5 monthsHabil Khorakiwala, Murtaza Khorakiwala and 1 more are mutual person
- Wockhardt Regenerative Private LimitedActive 4 years 22 days
Zahabiya Khorakiwala is a mutual person
Lysithea Trading & Services LlpActive 11 years 9 monthsHabil Khorakiwala and Murtaza Khorakiwala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wockhardt Bionova?
Wockhardt Bionova has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wockhardt Bionova, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wockhardt Bionova's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
